.Amgen has shared (PDF) the very first phase 3 data on its own $400 million chronic eczema medicatio...
.Biogen and also UCB's depend advancing right into stage 3 astride a broken research looks to have a...
.Italian biotech Aptadir Rehabs has actually launched with the commitment that its pipe of preclinic...
.Surge Life Sciences has satisfied its own goal in a Duchenne muscle dystrophy (DMD) research, placi...
.After a handful of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma fold...
.Achilles Therapies has torn up its approach. The British biotech is actually stopping work on its o...
.Aligos Therapies is actually trumpeting a midstage win in metabolic-dysfunction connected steatohep...
.Basilea Pharmaceutica's work creating new antifungals has gotten a significant increase coming from...
.Possessing already scooped up the U.S. civil liberties to Capricor Rehabs' late-stage Duchenne musc...
.After dismissing the selection date for Applied Therapeutics' metabolic ailment drug govorestat, th...